Reported 0 shares, down 215,540 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
|
This position's reported history falls outside the five-year preview window. A free account unlocks it.
Unlock full history
|
|||||||
Who else reported the position
65 managers reported OSMOTICA PHARMACEUTICALS PL for Q2 2021.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | Reduced | 1,668,279 | -262,502 | < 0.01% | $5,021,000 | 11 qtrs |
| RENAISSANCE TECHNOLOGIES LLC | Added | 973,102 | +6,595 | < 0.01% | $2,929,000 | 9 qtrs |
| JACOBS LEVY EQUITY MANAGEMENT INC | Reduced | 339,129 | -69,489 | < 0.01% | $1,021,000 | 2 qtrs |
| Rovida Advisors Inc | New | 300,308 | +300,308 | 0.04% | $901,000 | 1 qtr |
| VANGUARD GROUP INC | Reduced | 210,434 | -57,973 | < 0.01% | $634,000 | 11 qtrs |
| BlackRock Inc | Reduced | 167,250 | -1,150,685 | < 0.01% | $503,000 | 11 qtrs |
| MILLENNIUM MANAGEMENT LLC | New | 160,140 | +160,140 | < 0.01% | $482,000 | 1 qtr |
| GEODE CAPITAL MANAGEMENT LLC | Reduced | 155,718 | -85,013 | < 0.01% | $468,000 | 11 qtrs |
| Squarepoint Ops LLC | Reduced | 80,827 | -85,336 | < 0.01% | $243,000 | 7 qtrs |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | Reduced | 61,991 | -23,870 | < 0.01% | $187,000 | 11 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2021
- Filed
- July 30, 2021
- Filing type
- 13F-HR
- Position type
- SHS
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.